.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,023,269

« Back to Dashboard

Claims for Patent: 5,023,269

Title: 3-aryloxy-3-substituted propanamines
Abstract:The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.
Inventor(s): Robertson; David W. (Greenwood, IN), Wong; David T. (Indianapolis, IN), Krushinski, Jr.; Joseph H. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:07/499,940
Patent Claims: 1. A compound of the formula ##STR82## wherein: R.sup.1 is thienyl, halothienyl, (C.sub.1 -C.sub.4 alkyl)thienyl, furanyl, pyridyl or thiazolyl; ##STR83## each of R.sup.2 and R.sup.3 independently is hydrogen or methyl; each R.sup.4 independently is halo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.3 alkoxy or trifluoromethyl;

each R.sup.5 independently is halo, C.sub.1 C.sub.4 alkyl or trifluoromethyl;

m is 0, 1 or 2;

n is 0 or 1; and

the pharmaceutically acceptable acid addition salts thereof.

2. A compound of claim 1 wherein Ar is ##STR84##

3. A compound of claim 2 wherein R.sup.1 is halothienyl.

4. A compound of claim 2 wherein R.sup.1 is (C.sub.1 -C.sub.4 alkyl)thienyl.

5. A compound of claim 2 wherein R.sup.1 is furanyl.

6. A compound of claim 2 wherein R.sup.1 is pyridyl.

7. A compound of claim 2 wherein R.sup.1 is thiazolyl.

8. A compound of claim 2 wherein R.sup.1 is thienyl.

9. A compound of claim 8 wherein one of R.sup.2 and R.sup.3 is hydrogen and the other is methyl.

10. The compound of claim 10 which is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

11. The compound of claim 11 which is the (+) stereoisomer.

12. The compound of claim 12 which is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine maleate.

13. A compound of claim 1 wherein Ar is ##STR85##

14. A compound of claim 13 wherein R.sup.1 is thienyl.

15. A compound of claim 13 wherein R.sup.1 is halothienyl.

16. A compound of claim 13 wherein R.sup.1 is (C.sub.1 -C.sub.4 alkyl)thienyl.

17. A compound of claim 13 wherein R.sup.1 is furanyl.

18. A compound of claim 13 wherein R.sup.1 is pyridyl.

19. A compound of claim 13 wherein R.sup.1 is thiazolyl.

20. A method for inhibiting serotonin uptake in mammals which comprises administering to a mammal requiring increased neurotransmission of serotonin a pharmaceutically effective amount of a compound of claim 1.

21. A method of claim 20 wherein R.sup.1 is thienyl.

22. A method of claim 21 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

23. A method of claim 22 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

24. A method for inhibiting norepinephrine uptake in mammals which comprises administering to a mammal requiring increased neurotransmission of norepinephrine a pharmaceutically effective amount of a compound of claim 1.

25. A method of claim 24 wherein one of R.sup.2 and R.sup.3 is hydrogen and the other is methyl.

26. A method of claim 25 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

27. A method of claim 25 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

28. A method of treating depression in humans comprising administering to a human suffering from depression an effective antidepressant dose of a compound of claim 1.

29. A method claim 28 wherein R.sup.1 is thienyl.

30. A method of claim 29 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

31. A method of claim 30 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

32. A method of treating anxiety in human comprising administering to a human suffering from anxiety an effective antianxiety dose of a compound of claim 1.

33. A method of claim 32 wherein R.sup.1 is thienyl.

34. A method of claim 33 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

35. A method of claim 34 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

36. A method of treating obesity in humans comprising administering to a human suffering from obesity an effective antiobesity dose of a compound of claim 1.

37. A method of claim 38 wherein R.sup.1 is thienyl.

38. A method of claim 37 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

39. A method of claim 38 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

40. A method of suppressing the desire of humans to smoke comprising administering to a human in need of such suppression an effective dose to relieve the desire to smoke of a compound of claim 1.

41. A method of claim 40 wherein R.sup.1 is thienyl.

42. A method of claim 41 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

43. A method of claim 42 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

44. A method of suppressing the desire of humans to consume alcohol comprising administering to a human in need of such suppression an effective dose to relieve the desire to consume alcohol of a compound of claim 1.

45. A method of claim 44 wherein R.sup.1 is thienyl.

46. A method of claim 45 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

47. A method of claim 46 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

48. A pharmaceutical formulation comprising a compound of claim 1 and a pharmaceutically acceptable carrier, diluent or excipient therefor.

49. A formulation of claim 48 wherein R.sup.1 is thienyl.

50. A formulation of claim 49 wherein the compound is N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid addition salts.

51. A formulation of claim 50 wherein the compound is (+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, and its pharmaceutically acceptable acid.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc